对激素敏感前列腺癌治疗的个性化加强
Michael A Cilento1,2, Lisa M Butler1, Louise Emmett3,4
1South Australian Immunogenomics Cancer Institute, The University of Adelaide, Adelaide, South Australia, Australia.
Nature reviews. Clinical oncology
|November 27, 2025
概括
对激素敏感前列腺癌 (HSPC) 的全身治疗已经超越了单独的雄激素剥夺疗法 (ADT). 强化治疗,包括雄激素受体通路抑制剂 (ARPI) 和多塞,改善了特定患者群体的治疗结果.
科学领域:
- 在瘤学瘤学.
- 医学科学 医学科学 医学科学
背景情况:
- 荷尔蒙敏感前列腺癌 (HSPC) 历史上依赖于雄激素剥夺疗法 (ADT).
- 最近的进展利用更深入地了解前列腺癌生物学来加强治疗策略.
研究的目的:
- 审查非转移性和转移性HSPC的个性化管理.
- 讨论患者选择强化疗法和新兴治疗方法.
主要方法:
- 对目前和新兴的HSPC全身疗法的审查.
- 讨论诊断方式,包括前列腺特异性膜抗原PET等高级成像.
- 对多塞塔塞尔,ARPI和放射治疗的治疗选择标准的分析.
主要成果:
- 将ARPI和多塞塔克塞尔添加到ADT有益于特定的HSPC亚组.
- 新型药物,如AKT抑制剂,放射性连接体疗法和PARP抑制剂正在研究中.
- 先进的成像改善了早期检测和患者分层.
结论:
- 个性化治疗选择对于优化HSPC的结果至关重要.
- 新兴疗法和毒性减轻是未来管理的关键考虑因素.
- 整合新型成像和全身治疗为HSPC患者提供了量身定制的方法.
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


